-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, NoVaqfKX5CUnNoa+UAauUpZ9kY16mwG02Kko4z1FZhJsrErYysKnI+GDvUvxowKH 9C42qzPfG0mAA5hdROV+8A== 0000765258-02-000078.txt : 20021223 0000765258-02-000078.hdr.sgml : 20021223 20021223161450 ACCESSION NUMBER: 0000765258-02-000078 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20021220 FILED AS OF DATE: 20021223 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: TARNOWSKI S JOSEPH CENTRAL INDEX KEY: 0001177081 RELATIONSHIP: OFFICER FILING VALUES: FORM TYPE: 4 BUSINESS ADDRESS: STREET 1: IMCLONE SYSTEMS INC STREET 2: 180 VARICK STREET CITY: NEW YORK STATE: NY ZIP: 10014 BUSINESS PHONE: 6466385078 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: IMCLONE SYSTEMS INC/DE CENTRAL INDEX KEY: 0000765258 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 042834797 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19612 FILM NUMBER: 02867104 BUSINESS ADDRESS: STREET 1: 180 VARICK ST CITY: NEW YORK STATE: NY ZIP: 10014 BUSINESS PHONE: 2126451405 MAIL ADDRESS: STREET 1: 180 VARICK ST CITY: NEW YORK STATE: NY ZIP: 10014 4 1 form4dec2002.htm Form 4

 

FORM 4

 

__ Check this box if no longer 
     subject to Section 16. Form 4
     or Form 5 obligations may 
     continue. See Instruction 1(b).

     (Print or Type Responses)

 

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL
OMB Number: 3235-0287
Expires: January 31, 2005
Estimated average burden
hours per response. . . . 0.5

 

 

1.  Name and Address of Reporting Person*

 Tarnowski       S.      Joseph

 

2.  Issuer Name and Ticker or Trading Symbol

 ImClone Systems Incorporated (IMCL)

6.  Relationship of Reporting Person(s) to Issuer

(Check all applicable)

___   Director                              ___ 10% Owner

_X_  Officer (give title below)     ___Other (specify below)

  __Senior Vice President, Manufacturing Operations & Product Development______________

(Last)     (First)     (Middle)

C/O Imclone Systems Incorporated

180 Varick Street, 6th Floor          

3. I.R.S. Identification
    Number of Reporting
    Person, if an entity
    (voluntary)

4.  Statement for Month/Year

  December 20, 2002

 

(Street)

New York, New York 10014         

5.  If Amendment, Date of
 Original (Month/Year)

 

7.  Individual or Joint/Group Filing (Check Applicable Line)

_X_ Form filed by One Reporting Person

___ Form filed by More than One Reporting Person

(City)     (State)     (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

  

1.  Title of Security
   (Instr. 3)

2.  Transaction Date
(Month/Day/Year)

2A.  Deemed Execution Date,
if any
(Month/Day/Year)

3. Transaction Code
   (Instr. 8)

4. Securities  Acquired  (A)
    or Disposed of (D)
    (Instr. 3, 4 and 5)

5.  Amount of Securities
    Beneficially Owned
    Following Reported
    Transaction(s)
    (Instr. 3 and 4)

6.  Ownership
   Form: Direct
   (D) or
    Indirect (I)
    (Instr. 4)

 7.  Nature of
   Indirect
   Beneficial
   Ownership
   (Instr. 4)

Code

V

Amount

(A) or (D)

Price

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  



 

 

 

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1.Title of
   Derivative
   Security
   (Instr.3)

2.Conversion or
 Exercise Price of
 Derivative Security

3.Transaction Date
(Month/Day/Year)

3A.  Deemed
Execution Date,
if any
(Month/Day/Year)

4.Transaction Code
   (Instr. 8)

5.Number of Derivative
   Securities Acquired
   (A) or Disposed of (D)
   (Instr. 3, 4 and 5)

6.Date Exerciseable
   and Expiration  Date
  (Month/Day/Year)

7.Title and  Amount of
   Underlying Securities
   (Instr. 3 and 4)

8.Price of
   Derivative
   Security
   (Instr. 5)

9.Number  of
   Derivative
   Securities
   Beneficially
   Owned
   Following
   Reported
   Transaction(s)
    (Instr. 4)

10.Ownership
     Form of
     Derivative
     Securities
     Beneficially
     Owned at
     End of Month
     (Instr. 4)

11.Nature  of
     Indirect
     Beneficial
     Ownership
     (Instr. 4)

Code

V

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Employee Stock Option (Right to Buy)

  $11.91

 12/20/2002       A   7,500

  

 (*) 12/19/2012 Common Stock 7,500 $11.91 7,500         D

      ______   

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

 

Explanation of Responses: (*) These employee stock options become exercisable in two equal annual installments beginning December 20, 2003.
 
 
 
 

 

                         /s/ S. Joseph Tarnowski                         
**Signature of Reporting Person

                    12/23/2002                                 
Date

 

Reminder:

Report on a separate line for each class of securities beneficially owned directly or indirectly.

*

If the form is filed by more than one reporting person, see Instruction 4(b)(v).

**

Intentional misstatements or omissions of facts constitute Federal Criminal Violations
See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note:

File three copies of this Form, on of which must be manually signed. If space is insufficient, see Instruction 6 for procedure

 -----END PRIVACY-ENHANCED MESSAGE-----